- Home
- DRIO vs CLNN Comparison
DRIO vs CLNN Comparison
Compare DRIO & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRIO | CLNN |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | 76 |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 69.7M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | DRIO | CLNN |
|---|---|---|
| Price | $8.42 | $5.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $60.00 | $32.67 |
| AVG Volume (30 Days) | 7.7K | ★ 59.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.05 | N/A |
| Revenue | ★ $7,394,000.00 | N/A |
| Revenue This Year | N/A | $42.80 |
| Revenue Next Year | $16.15 | $25,771.15 |
| P/E Ratio | $0.99 | ★ N/A |
| Revenue Growth | ★ 43.02 | N/A |
| 52 Week Low | $0.38 | $2.28 |
| 52 Week High | $17.74 | $13.50 |
Technical Indicators
Market Signals| Indicator | DRIO | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 34.60 | 63.94 |
| Support Level | $0.56 | $5.59 |
| Resistance Level | $12.36 | $6.88 |
| Average True Range (ATR) | 0.62 | 0.49 |
| MACD | -0.16 | 0.11 |
| Stochastic Oscillator | 18.74 | 69.74 |
Price Performance
Historical ComparisonAbout DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.